Skip to main content
Caplight Logo









Cognos Therapeutics Inc

Cognos Therapeutics Inc

Private
Inglewood, CaliforniaHealthcare & Life Scienceshttps://cognosthx.com/

Last Round

Seed Round

Jul 2, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cognos Therapeutics Inc is a medical technology company developing the SINNAIS™, an implantable smart pump for targeted drug delivery to treat neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

implantable infusion pumpdrug delivery systemprecision medicineneurological disease treatmentmedical device developersmart implanttargeted drug deliveryoncology deviceclosed-loop systemmedtechbiosensorbiotechremote monitoringdrug-device combinationdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cognos Therapeutics Inc Comparables

Compare Cognos Therapeutics Inc with similar companies based on industry and business-model similarity.

Cognos Therapeutics Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theracle
88%
CraniUS Therapeutics
86%
Precision NeuroMed
85%

Cognos Therapeutics Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 2, 2026

Key People

Founding team and executive leadership

Frank Adell

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    $250K raised in Seed Round.

  • Feb 24, 2025

    Monthly visitors increased 72% MoM, reaching 1.7K.

Recent news

Latest coverage and updates

  • hiresJul 6, 2026

    Cognos Therapeutics, Inc. hired miguel Adao on Jul 6th '26.

  • hiresJul 6, 2026

    Cognos Therapeutics, Inc. hired Adao on Jul 6th '26.

Cognos Therapeutics Inc Filings

Explore SEC and related filing metadata, where available.

Cognos Therapeutics Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cognos Therapeutics Inc's valuation, stock price, and market status.

Is Cognos Therapeutics Inc a public or private company?

Cognos Therapeutics Inc is a private company.

What is the current stock price of Cognos Therapeutics Inc?

Cognos Therapeutics Inc is a private company with no public stock price. No recent secondary market data is available.

How much is Cognos Therapeutics Inc worth (valuation)?

Valuation information for Cognos Therapeutics Inc is not publicly available.

Can I buy Cognos Therapeutics Inc stock?

Cognos Therapeutics Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cognos Therapeutics Inc's last funding round?

Cognos Therapeutics Inc's most recent funding round was Seed Round on July 2, 2026.

Who are the main investors in Cognos Therapeutics Inc?

Investor information for Cognos Therapeutics Inc is not publicly disclosed.

Will Cognos Therapeutics Inc IPO soon?

No public IPO plans have been announced for Cognos Therapeutics Inc.

How can I track Cognos Therapeutics Inc secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cognos Therapeutics Inc's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersInglewood, California
Employee Range8
Year Founded2003
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?